gallbladder adenocarcinoma
gallbladder adenocarcinoma
Explore linked clinical trials. Standard reference: MONDO:00062153 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating Novel Therapies in ctDNA Positive GI Cancers | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, colon adenocarcinoma, colonic disorder, colonic neoplasm, colorectal neoplasm, digestive system disorder, digestive system neoplasm, epithelial neoplasm, gallbladder adenocarcinoma, gastric adenocarcinoma, hepatocellular carcinoma, intestinal disorder, liver disorder, neoplasm, pancreatic adenocarcinoma, rectal disorder, rectal neoplasm, rectum adenocarcinoma | Active, not recruiting | Phase 3 | 2026-10-06 | NCT05482516 | |
| Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels | Neoplasms by Histologic Type, adenocarcinoma, ampulla of vater adenocarcinoma, carcinoma, cholangiocarcinoma, duodenal adenocarcinoma, epithelial neoplasm, esophageal adenocarcinoma, gallbladder adenocarcinoma, gastric adenocarcinoma, gastroesophageal adenocarcinoma, neoplasm, pancreatic adenocarcinoma | Recruiting | Phase 2 | 2026-09-08 | NCT07282912 | |
| Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma | gallbladder adenocarcinoma | Recruiting | Early phase 1 | 2026-04-20 | NCT05430035 |